Dexcom and Livongo Q3 ’19 Earnings Updates
Dexcom and Livongo hosted their Q3 ’19 earnings calls and provided updates to their respective businesses. Below, FENIX provides highlights and insights from the respective earnings calls.
Dexcom and Livongo hosted their Q3 ’19 earnings calls and provided updates to their respective businesses. Below, FENIX provides highlights and insights from the respective earnings calls.
Intarcia announced FDA accepted the ITCA-650 re-filing, nearly 2 years after it received a CRL. Additionally, Dexcom announced it received FDA clearance for a new G6 professional CGM. Below, FENIX provides thoughts and insights on the respective news items.
Dexcom announced the G6 CGM will be available to Medicare patients starting early 2019. Additionally, Dexcom has entered into an agreement with Validic to integrate Dexcom CGM data into Validic’s data connectivity platform, called Validic Inform, which streams data from in-home connected devices into HCP systems. Below, FENIX provides thoughts on G6 Medicare availability as well as reasons why the Validic partnership makes sense for Dexcom.